Economics of transurethral thermotherapy of the prostate

World Journal of Urology

Volumn 16, Issue 2, 1998, Pages 138-141

  Jepsen, Jan V ^a   Bruskewitz, Reginald C ^a  

^a Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST; DIATHERMY; ECONOMICS; HUMAN; MALE; METHODOLOGY; MICROWAVE RADIATION; PROSTATE HYPERTROPHY; REVIEW; STATISTICAL MODEL; URETHRA;

COSTS AND COST ANALYSIS; DIATHERMY; HUMANS; MALE; MICROWAVES; MODELS, ECONOMIC; PROSTATIC HYPERPLASIA; URETHRA;

EID: 0032400373     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450050040     Document Type: Article

References (20)

1. Ahlstrand C, Carlsson P, Jönsson B (1995) Estimated total costs of treating benign prostatic hyperplasia in Sweden. Scand J Urol Nephrol 29: 57-63
2. Ahlstrand C. Carlsson P, Jönsson B (1996) An estimate of the life-time cost of surgical treatment of patients with benign prostatic hyperplasia in Sweden. Scand J Urol Nephrol 30: 37-43
3. Blute M, Hanson K, Lynch J, et al (1996) United States Prostatron TUMT study - 4 year follow-up and quality of life (abstract 370). J Urol 155: 403A
4. Chirikos TN, Sanford E (1996) Cost consequences of surveillance, medical management or surgery for benign prostatic hyperplasia. J Urol 155: 1311-1316
5. De La Rosette JJMCH, D'Ancona FCH, Debruyne FMJ (1997) Current status of thermotherapy of the prostate. J Urol 157: 430-438
6. De Wildt MJAM, D'Ancona FCH, Hubregtse M, Carter SSTC, Debruyne FMJ, De la Rosette JJMCH (1996) Threeyear followup of patients treated with lower energy microwave thermotherapy. J Urol 156: 1959-1963
7. Drummond MF. McGuire AJ, Petticrew M, McPherson CK (1993) Economic burden of treated benign prostatic hyperplasia in the United Kingdom. Br J Urol 71: 290-296
8. Holtgrewe HL (1995) Economic issues and the management of benign prostatic hyperplasia. Urology 46 [Suppl 3A]: 23-25
9. Holtgrewe HL, et al (1996) Report from the committee on the economics of BPH. In: Cockett ATK. et al (eds) Proceedings from the 3rd international consultation on benign prostatic hyperplasia. Scientific Communication International. Jersey, UK, pp 53-63
10. Keoghane SR, Lawrence KC, Gray AM, Chappel DB, Hancock AM. Cranston DW (1996) The Oxford Laser Prostate Trial: economic issues surrounding contact laser prostatectomy. Br J Urol 77: 386-390
11. Kortt MA, Bootman JL (1996) The economics of benign prostatic hyperplasia treatment: a literature review. Clin Ther 18: 1227-1241
12. Lowe FC, McDaniel RL, Chmiel JJ, Hillman AL (1995) Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia. Urology 46: 477-183
13. Mayer R, Blute M, Bruskewitz R, Larson T, Utz W (1997) U.S. multi-center study results of a new high temperature microwave system for BPH show improvements in patients symptoms and flow rates without compromise in morbidity and anesthetic need (abstract 369). J Urol 157: 95
14. McConnell JD, Barry MJ, Bruskewitz RC, et al (1994) Benign prostatic hyperplasia: diagnosis and treatment. Clinical practice guideline 8. AHCPR publication 94-0582. Agency for Health Care Policy and Research, public Health Service, U.S. Department of Health and Human Services, Rockville, Maryland
15. Merliere Y, Viens-Bitker C. Houee J, Dutheil M, Abbou C (1994) The economic evaluation of prostatic hyperthermia (abstract, in French). Prog Urol 4: 547-554
16. Mueller EJ, Zeidman EJ, Desmond PM, Thompson IM, Optenberg SA. Wasson J (1996) Reduction of length of stay and cost of transurethral resection of the prostate by early catheter removal. Br J Urol 78: 893-896
17. Scott WG, Scott HM (1993) Annual costs of benign prostatic hyperplasia in New Zealand. Pharmacoeconomics 4: 455-68
18. Standaert B, Torfs K (1994) Economics of BPH: measuring the intangible costs. In: Kurth K, Newling DWW (eds) Benign prostatic hyperplasia: recent progress in clinical research and practice. Wiley-Liss, New York, pp 409-418
19. Vale JA. Bdesha AS, Witherow RON (1995) An analysis of the costs of alternative treatments for benign prostatic hyperplasia. J R Soc Med 88: 644-648
20. Woodward R, Boyarsky S, Barnett H (1983) Discounting surgical benefits. Enucleation versus resection of the prostate. J Med Syst 7: 481-493